BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.94% | 49.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.94% | 49.85% | |||
| Cost of Revenue | -16.69% | 32.34% | |||
| Gross Profit | 17.66% | -30.15% | |||
| SG&A Expenses | 10.51% | 4.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.65% | 25.03% | |||
| Operating Income | 10.72% | -22.83% | |||
| Income Before Tax | 14.22% | -28.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.22% | -28.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.22% | -28.62% | |||
| EBIT | 10.72% | -22.83% | |||
| EBITDA | 10.73% | -22.79% | |||
| EPS Basic | 26.95% | -27.44% | |||
| Normalized Basic EPS | 26.94% | -27.41% | |||
| EPS Diluted | 26.95% | -27.44% | |||
| Normalized Diluted EPS | 26.94% | -27.41% | |||
| Average Basic Shares Outstanding | 17.41% | 0.92% | |||
| Average Diluted Shares Outstanding | 17.41% | 0.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||